This patent teaches how to induce mesenchymal stem cells into chondrocytes (to make cartilage) or osteoblasts (to make bone) through the use of the cytokine called Connective Tissue Growth Factor.
This patent is useful for regenerative purposes in the area of injuries, however it is interesting in that the mesenchymal stem cell patents are owned by Osiris and should be licensed in order to utilize this invention.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.